1154059-17-2Relevant articles and documents
BIS-(SULFONYLAMINO) DERIVATIVES IN THERAPY 065
-
Page/Page column 33, (2009/05/28)
The invention provides compounds of formula wherein R1, R2, R3, A and m are as defined in the specification and optical isomers, racemates and tautomers thereof, and pharmaceutically acceptable salts thereof; together with processes for their preparation, pharmaceutical compositions containing them and their use in therapy. The compounds are inhibitors of microsomal prostaglandin E synthase-1